The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients

被引：0
|
作者：
Vance J. Bray
Aaron Broadwell
Herbert S. B. Baraf
Shawn Black
Brenna L. Brady
Joseph Tkacz
Lorraine Yarngo
Raphael J. DeHoratius
机构：
[1] Denver Arthritis Clinic,Sidney Kimmel School of Medicine
[2] Rheumatology and Osteoporosis Specialists,undefined
[3] Arthritis and Rheumatism Associates,undefined
[4] Health Analytics,undefined
[5] Janssen Medical Affairs,undefined
[6] Thomas Jefferson University,undefined
来源：
Drugs in R&D | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：211 / 219
页数：8
相关论文
共 50 条
  • [1] The Effectiveness of Intravenous Golimumab Administered Directly After Infliximab in Rheumatoid Arthritis Patients
    Bray, Vance J.
    Broadwell, Aaron
    Baraf, Herbert S. B.
    Black, Shawn
    Brady, Brenna L.
    Tkacz, Joseph
    Yarngo, Lorraine
    DeHoratius, Raphael J.
    DRUGS IN R&D, 2018, 18 (03) : 211 - 219
  • [2] EFFECTIVENESS AND SAFETY OF INFLIXIMAB, GOLIMUMAB AND GOLIMUMAB-IV IN RHEUMATOID ARTHRITIS PATIENTS FROM A PROSPECTIVE OBSERVATIONAL REGISTRY
    Rahman, Proton
    Baer, Philip
    Choquette, Denis
    Faraawi, Rafat
    Bessette, Louis
    Baker, Milton
    Rai, Raman
    Kelsall, John
    Lisnevskaia, Larissa
    Reis, Jodie
    Anderson, Keltie
    Olszynski, Wojciech
    Rampakakis, Emmanouil
    Miilan, Odalis Asin
    Lehman, Allen
    Rachich, Meagan
    Nantel, Francois
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 721 - 722
  • [3] Intravenous golimumab in rheumatoid arthritis
    Cohen, Marc D.
    Keystone, Edward C.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (07) : 823 - 830
  • [4] Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study
    Jeffrey R. Curtis
    Soumya D. Chakravarty
    Shawn Black
    Shelly Kafka
    Stephen Xu
    Wayne Langholff
    Dennis Parenti
    Andrew Greenspan
    Sergio Schwartzman
    Rheumatology and Therapy, 2021, 8 : 1551 - 1563
  • [5] Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study
    Curtis, Jeffrey R.
    Chakravarty, Soumya D.
    Black, Shawn
    Kafka, Shelly
    Xu, Stephen
    Langholff, Wayne
    Parenti, Dennis
    Greenspan, Andrew
    Schwartzman, Sergio
    RHEUMATOLOGY AND THERAPY, 2021, 8 (04) : 1551 - 1563
  • [6] EFFECTIVENESS AND SAFETY OF INFLIXIMAB, GOLIMUMAB AND GOLIMUMAB-IV IN RHEUMATOID ARTHRITIS FROM A LONGITUDINAL OBSERVATIONAL REGISTRY
    Rahman, Proton
    Baer, Philip
    Choquette, Denis
    Olszynski, Wojciech
    Faraawi, Rafat
    Bessette, Louis
    Baker, Milton
    Rai, Raman
    Kelsall, John
    Lisnevskaia, Larissa
    Reis, Jodie
    Anderson, Keltie
    Rampapakis, Emmanouil
    Asin-Milan, Odalis
    Lehman, Allen J.
    Nantel, Francois
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S44 - S44
  • [7] Effectiveness of golimumab in clinical management of patients with rheumatoid arthritis
    Shono E.
    Drugs in R&D, 2013, 13 (1) : 95 - 100
  • [8] Long-Term Effectiveness and Safety of Infliximab, Golimumab and Golimumab-IV in Rheumatoid Arthritis Patients from a Prospective Observational Registry
    Rahman, Proton
    Baer, Philip
    Choquette, Denis
    Olszynski, Wojciech
    Faraawi, Rafat
    Bessette, Louis
    Baker, Milton
    Rai, Raman
    Kelsall, John
    Lisnevskaia, Larissa
    Reis, Jodie
    Anderson, Keltie
    Rampakakis, Emmanouil
    Rachich, Meagan
    Asin-Milan, Odalis
    Lehman, Allen
    Nantel, Francois
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [9] Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry
    Tesser, John
    Lin, Iris
    Shiff, Natalie J.
    Chakravarty, Soumya D.
    Schmajuk, Gabriela
    Hammam, Nevin
    Desai, Sheetal
    CLINICAL RHEUMATOLOGY, 2022, 41 (08) : 2319 - 2327
  • [10] Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry
    John Tesser
    Iris Lin
    Natalie J. Shiff
    Soumya D. Chakravarty
    Gabriela Schmajuk
    Nevin Hammam
    Sheetal Desai
    Clinical Rheumatology, 2022, 41 : 2319 - 2327
12345